Skip to main content
. 2020 Dec 16;10(1):e018186. doi: 10.1161/JAHA.120.018186

Figure 3. Fibrosis progression from 1 to 3 years in the total cohort, CNI and sirolimus groups.

Figure 3

CNI indicates calcineurin inhibitors.